US pharmaceutical group is developing a single-dose vaccine for the virus
Home/FT/J&J halts Covid-19 vaccine trial after participant’s ‘adverse reaction’ FT J&J halts Covid-19 vaccine trial after participant’s ‘adverse reaction’ Financial Times0 Less than a minute Facebook X LinkedIn US pharmaceutical group is developing a single-dose vaccine for the virus Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on WhatsApp (Opens in new window) WhatsApp Email a link to a friend (Opens in new window) Email Related Financial Times0 Less than a minute Facebook X LinkedIn Facebook X LinkedIn Tumblr Pinterest Reddit VKontakte Share via Email Print
